Clinical Trials Logo

Pancreatic Cancer Stage III clinical trials

View clinical trials related to Pancreatic Cancer Stage III.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03252808 Active, not recruiting - Clinical trials for Pancreatic Cancer Stage IV

Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients With Unresectable Pancreatic Cancer.

Start date: September 25, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the recommended dose of TBI-1401(HF10) treatment in combination with chemotherapy (Gemcitabine + Nab-paclitaxel or TS-1) in patients with stage III or IV unresectable pancreatic cancer.